Predictive Success Factors in Selective Upper Airway Stimulation

Area of Science:

• Sleep Medicine
• Otolaryngology
• Biomarker Research

Background:

• Obstructive sleep apnea (OSA) is a prevalent condition in industrialized nations.
• Established treatments for OSA include conservative measures and surgery.
• Selective upper airway stimulation (sUAS) has emerged as a safe and effective therapeutic option.

Purpose of the Study:

• To investigate biomarkers predictive of clinical success in selective upper airway stimulation (sUAS) for obstructive sleep apnea (OSA).
• To evaluate the role of patient-specific factors, such as age and weight, in predicting sUAS outcomes.
• To explore novel methodologies for assessing surgical success and guiding future treatment strategies in sUAS.

Main Methods:

• Review of clinical trials investigating predictive factors for sUAS success.
• Analysis of the influence of age and body mass index (BMI) on treatment outcomes.
• Application of nerve integrity monitoring for predicting cuff placement during surgery.
• Exploration of postoperative sonography as an assessment tool for predictive markers.

Main Results:

• Age is not a significant predictive factor for sUAS success, unlike in other OSA therapies.
• Weight plays a limited role, with drug-induced sleep endoscopy (DISE) necessary to rule out concentric collapse in obese patients.
• Nerve integrity monitoring aids in predicting correct cuff placement for surgical success and postoperative tongue function.

Conclusions:

• Biomarkers for predicting selective upper airway stimulation (sUAS) success are under investigation.
• Age and weight have minimal predictive value for sUAS outcomes.
• Nerve integrity monitoring and postoperative sonography represent promising future methods for assessing predictive markers in sUAS therapy.